|
|
| |
|
| |
 |
EVIDENCE BASED REVIEWS IN SURGERY
a joint program of the
CANADIAN ASSOCIATION OF GENERAL SURGEONS
L'ASSOCIATION CANADIENNE DES CHIRURGIENS GÉNÉRAUX
&
AMERICAN COLLEGE OF SURGEONS |
 |
Evidence Based Reviews in Surgery - Archives
EBRS packages are available dating back to 2000. If you would like access to any of these packages/articles, you can do so by accessing the following:
- Chronologically (by month and year) This allows access to the complete package, included are the questions related to the methodology, the methodological and clinical articles and the methodological and clinical reviews.
- Index of Methodological and Clinical Topics This allows you to access either the methodological or clinical topics of interest; a list of articles will appear. To retrieve an article on this topic you can click on it and it will bring up the article.
Display all in chronological order
May 2009
Topics
|
1. Clinical Topic:
|
The Use of Insulin Therapy and Pentaspan in Severe Sepsis |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted form and attributed at its conclusion?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. The Use of Insulin Therapy and Pentaspan in Severe Sepsis; Brunkhorst FM, Engel C, Bloos F, et al; Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. N Engl J Med 2008;358:125-39 |
2. Appendix re methodology; Added Reading Appendix re methodology: Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39. |
3. How to use an article about therapy or prevention (b); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1994 Jan 5; 271(1): 59-63 |
4. How to use an article about therapy or prevention (a); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1993 Dec 1; 270(21): 2598-2601 |
| | | Reviews |
|
Clinical Review (Can):
|
John Marshall - University of Toronto
|
|
Clinical Review (US):
|
Lena Napolitano - University of Michigan
|
|
Methodological Review:
|
Prosanto Chaudhury - McGill University
|
April 2009
Topics
|
1. Clinical Topic:
|
Lower Incidence of VTE in Laparoscopic vs. Open Surgery |
|
2. Methodological Topic:
|
Causation/Risk Factors |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were there clearly identified comparison groups that were similar with respect to important determinants of outcome other than the one of interest?
- Were the exposures and outcomes measured in the same way in the groups being compared?
- Was follow-up sufficiently long and complete?
- Is the temporal relationship correct?
- Is there a dose-response gradient?
- How strong is the association between exposure and outcome?
- How precise is the estimate of the risk?
- Are the results applicable to my practice?
- What is the magnitude of the risk?
- Should I attempt to stop the exposure?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Lower Incidence of VTE in Laparoscopic vs Open Surgery; Nguyen NT, Hinojosa MW, Fayad C, et al; Laparoscopic Surgery is Associated with a Lower Incidence of Venous Thromboembolism Compared with Open Surgery. Ann Surg 2007;246(6):1021-27 |
2. How to use an article about harm; Mitchell L, Walter S, Lee H, Haines T, Holbrook A, Moyer V, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. IV. How to Use an Article about Harm. JAMA 1994; 271(20): 1615-1619 |
| | | Reviews |
|
Clinical Review (Can):
|
Dan Birch - University of Alberta
|
|
Clinical Review (US):
|
Joseph Caprini - Northwestern University
|
|
Clinical Review (US):
|
Lee Swanstrom - Oregon Health Science University
|
|
Methodological Review:
|
Tara Mastracci - Cleveland Clinic
|
March 2009
Topics
|
1. Clinical Topic:
|
Student Quality of Life Declines During Third Year Surgical Clerkship |
|
2. Methodological Topic:
|
Quality of Life |
| |
|
Questions
|
- What is the clinical question being addressed?
- Have the investigators measured aspects of students' lives that students consider important?
- Did the HRQL Instruments work in the way they are supposed to?
- Are there important aspects of HRQL that have been omitted?
- What was the magnitude of the effect on HRQL?
- Will the information from the study help inform other students and medical educators?
- Was the setting similar to that of most medical schools and clerkships?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Student Quality of Life Declines During Third Year Clerkship; Goldin SB, Wahi MM, Farooz OS et al; Student Quality-of-Life Declines During Third Year Surgical Clerkship. J of Surg Research 2007;143(1):151-57 |
2. How to use articles about health related quality of life; Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ, for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. XII. How to Use Articles About Health-Related Quality of Life. JAMA 1997; 277 (15): 1232-1237 |
| | | Reviews |
|
Clinical Review (Can):
|
Sarkis Meterissian - McGill University
|
|
Clinical Review (US):
|
Rebecca Evangelista - Georgetown University/Stephen Evans - Georgetown University
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
February 2009
Topics
|
1. Clinical Topic:
|
Use of Colonic Stents in Emergent Malignant Left Colonic Obstruction |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were all of the realistic clinical strategies compared?
- Were all clinically relevant outcomes considered?
- Was an explicit an sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was the potential impact of any uncertainty in the evidence determined in the baseline analysis?
- Does one strategy result in a clinically important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncertainty in the evidence change the results?
- Do the probability estimates fit my patients'clinical features?
- Do the utilities reflect how my patients would value the outcomes of the decision?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Use of Colonic Stents in Emergent Malignant Left Colonic Obstruction; Govindarajan A, Naimark D, Coburn NG, et al; Use of Colonic Stents in Emergent Malignant Left Colonic Obstruction: A Markov Chain Monte Carlo Decision Analysis. Dis Colon Rectum 2007;50(11):181-24 |
2. How to use a Clinical Decision Analysis - A;
Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995;273(16):1292-95 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(20): 1610-1613 |
| | | Reviews |
|
Clinical Review (Can):
|
John Heine - University of Calgary
|
|
Clinical Review (US):
|
Heidi Nelson - Mayo Clinic Rochester
|
|
Methodological Review:
|
Harry Henteleff - Dalhousie University/Suzanne Cutter - Cedars Sinai Medical Center, Los Angeles
|
January 2009
Topics
|
1. Clinical Topic:
|
Nonsurgical Treatment of Appendiceal Abscess or Phlegmon |
|
2. Methodological Topic:
|
Meta-analysis - non experimental design |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the review explicity address a sensible clinical question?
- Was the search for relevant studies detailed and exhaustive?
- Was there a qualitative and/or quantitative assessment of heterogeneity?
- Are the interventions adequately described?
- Were the clinically important outcomes considered?
- Was there adequate reporting of results including descriptive information of each study?
- What are the overall results of the review?
- Was there an assessment of potential biases?
- Was there a discussion of what future research is required?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Nonsurgical Treatment of Appendiceal Abscess or Phlegmon; Andersson RE, Petzold MG; Nonsurgical Treatment of Appendiceal Abscess or Plegmon. A Systematic Review and Meta-analysis. Ann Surg 2007;246(5):741-48 |
2. Meta-analysis of Observational Studies in Epidemiology; Stroup DF, Berlin JA, Morton SC, et al for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group; Meta-analysis of Observational Studies in Epidemiology. JAMA 2000;283(15):2008-12 |
| | | Reviews |
|
Clinical Review (Can):
|
Susan Reid - McMaster University
|
|
Clinical Review (US):
|
Neil Hyman - University of Vermont
|
|
Methodological Review:
|
Steve Latosinsky - University of Manitoba
|
December 2008
Topics
|
1. Clinical Topic:
|
Prophylactic Antibiotics for Mesh Inguinal Hernioplasty |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the review explicitly address a sensible clinical question?
- Was the search for relevant studies detailed and exhaustive?
- Were the primary studies of high methodologic quality?
- Were assessments of studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the review?
- How precise were the results?
- Were the clinically important outcomes considered?
- Are the benefits worth the costs and potential risks?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Prophylactic Antibiotics for Mesh Inguinal Hernioplasty; Sanabria A, Dominguez LC, Valdiviseso E, Gomez G; Prophylactic Antibiotics for Mesh Inguinal Hernioplasty. A Meta-analysis. Ann Surgery 2007;245(3):392-96 |
2. Systematic Review and Meta-analysis; Bhandari M, Devereaux PJ, Montore V, et al; for the Evidence Based Surgery Working
Group. Users’ Guide to Surgical Literature: How to Use a Systematic Review and Meta-
analysis. CJS 2004;47(1):60-67 |
| | | Reviews |
|
Clinical Review (Can):
|
Brock Vair - Dalhousie University
|
|
Clinical Review (US):
|
Jon S.Thompson - University of Nebraska
|
|
Methodological Review:
|
Leigh Neumayer - University of Utah
|
November 2008
Topics
|
1. Clinical Topic:
|
CT Angiography for Diagnosis of Blunt Cervical Vascular Injury |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being addressed?
- Is there an independent, blind comparison with a reference standard?
- Does the study sample include an appropriate spectrum of patients to which the diagnostic test is to applied?
- Do the results of the test being evaluated influence the decision to perform the reference standard test?
- Are the methods for performing the test described in sufficient detail to permit replication?
- Are likelihood ratios for the test results, presented or is the data necessary for their calculation included?
- Will the reproducibility of the result and its interpretation be satisfactory in my setting?
- Are the results applicable to my patient?
- Will the results change my management?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. CT Angiography for Diagnosis of Blunt Cervical Vascular Injury; Eastman AL, Chason DP, Perez CL, et al; Computed Tomographic Angiography for the Diagnosis of Blunt Cervical Vascular Injury: Is It Ready for Primetime? J Trauma 2006;60(5):925-29 |
2. How to use an article about a diagnostic test; Archibald S, Bhandari M, Thoma A, for the Evidence-Based Surgery Working Group. Users’ Guides to the Surgical Literature: How to Use an Article about a Diagnostic Test. CJS 2001;44(1):17-23 |
| | | Reviews |
|
Clinical Review (Can):
|
David Evans - University of British Columbia
|
|
Clinical Review (US):
|
Wayne Meredith - Wake Forest University
|
|
Methodological Review:
|
Andrew Kirkpatrick - Univeristy of Calgary
|
October 2008
Topics
|
1. Clinical Topic:
|
On-Demand vs. Planned Relaparotomy for severe peritonitis |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect? Calculate 95% CI around the difference in 30 day mortality rates between groups.
- State the estimates upon which the sample size was calculated. In retrospect, were they accurate?
- Can the reslults be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. On-Demand vs. Planned Relaparotomy for Severe Peritonitis; van Ruler O, Mahler CW, Boer KR, et al; Comparison of On-Deman vs. Planned Relaparotomy Strategy in Patients with Severe Peritonitis. A Randomized Trial. JAMA 2007;298(8):865-73 |
2. How to Use an Article Evaluating Surgical Interventions; Urschel JD, Goldsmith CH, Tandan VR, Miller JD; for the Evidence-Based Surgery Working Group. Users' Guide to Evidence-Based Surgery: How to Use an Article Evaluating Surgical Interventions CJS 2001; 44(2): 95-100 |
| | | Reviews |
|
Clinical Review (Can):
|
Morad Hameed - University of British Columbia
|
|
Clinical Review (US):
|
Michael Sarr - Mayo Clinic Rochester
|
|
Methodological Review:
|
Karen Brasel - Medical College of Wisconsin
|
May 2008
Topics
|
1. Clinical Topic:
|
Urban vs. rurual inpatient case mix difference |
|
2. Methodological Topic:
|
Administrative Data |
| |
|
Questions
|
- What is the clinical question being addressed?
- What is the source of the data?
- Are the data accurate and valid?
- What medical services were assessed? How are they ascertained?
- Are the differences in the rates of use of medical services clinically significant?
- Are there any factors that might explain the diffferences in use of medical services?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
- Can these data be used to implement changes in health care provision and if so, how?
|
|
Articles
|
1. Urban vs rurual inpatient case mix differences; VanBibber M, Zuckerman RS, Finlayson SRG; Rural Versus Urban Inpatient Case-Mix Differences in the US. J Am Coll Surg. 2006; 203(6): 812-16 |
2. Small-Area variations: what are they and what do they mean?; Health Services Research Group. Small-Area Variations: What are They and What do They Mean? CMAJ. 1992;146(4):467-70 |
| | | Reviews |
|
Clinical Review (Can):
|
Bill Pollett - Memorial University
|
|
Clinical Review (US):
|
Tom Cogbill - Gunderson Lutheran Medical Center
|
|
Methodological Review:
|
Andrew Kirkpatrick - University of Calgary
|
April 2008
Topics
|
1. Clinical Topic:
|
SLNB vs. standard axillary treatment in operable breast ca |
|
2. Methodological Topic:
|
Quality of Life |
| |
|
Questions
|
- What is the clinical question being addressed?
- Have the investigators measured aspects of patients' lives that patients consider important?
- Did the HRQL instruments work in the way they are supposed to?
- Are the important aspects of HRQL that have been omitted?
- If there were trade-offs between quality and quantity of life, or an economic evaluation, have the investigators used the right measure?
- What was the magniturd of the effect on HRQL?
- Will the information from the study help me inform my patients?
- Did the study design simulate the clinical practice?
- State the conclusion. Have the authors addressed the clinical question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. SNLB vs standard axillary treatment in operable breast ca; Mansel RE, Fallowfield L, Kissin M, et al; Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANC Trial. J Natl Cancer Inst 2006; 98(9): 599-609 |
2. How to use an article about health related quality of life; Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ, for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. XII. How to Use Articles About Health-Related Quality of Life. JAMA 1997; 277 (15): 1232-1237 |
| | | Reviews |
|
Clinical Review (Can):
|
Kelly Dabbs - University of Alberta
|
|
Clinical Review (US):
|
Fred Moffat - University of Miami
|
|
Methodological Review:
|
Steve Latosinsky - University of Manitoba
|
March 2008
Topics
|
1. Clinical Topic:
|
Simple scoring system for predicting acute pancreatitis |
|
2. Methodological Topic:
|
Prognosis/Natural History |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was there a representative and well-defined sample of patients at a similar point in the course of the disease?
- Was follow-up sufficiently long and complete?
- Were objective unbiased outcome criteria used?
- Was there adjustment for important prognositc factors?
- How large is the likelihood of the outcome evient(s) in a specified period of time?
- How precise are the estimates of likelihood?
- Weill the results help me in caring for my patients?
- Will the results lead directly to selecting or avoiding therapy?
- Are the results useful for reassuring or counselling patients?
- State the conclusion. Have the authors addressed the clinical question?
- Does the evidence suppport the conclusion?
|
|
Articles
|
1. Simple scoring system for the prediction of acute pancreatitis; Ueda T, Takeyama Y, Yasuda T, et al; Simple scoring system for the prediction of the prognosis of severe acute pancreatitis. Surgery 2007; 141 (1): 51-8 |
2. Prognositc factors in acute pancreatitis;
Ranson JHC, Rifkind KM, Roses DF et al; Prognostic Signs and the Role of Operative Management in Acute Pancreatitis. Surgery, Gynecology & Obstetrics 1974;139:69-81 |
3. How to use an article about prognosis; Laupacis A, Wells G, Richardson WS, Tugwell P, for The Evidence-Based Working Group: Users' Guides to the Medical Literature. V. How to Use an Article About Prognosis. JAMA 1994; 272: 234-237 |
| | | Reviews |
|
Clinical Review (Can):
|
Elijah Dixon - University of Calgary
|
|
Clinical Review (US):
|
Karen Horvath - University of Washington
|
|
Methodological Review:
|
Leigh Neumayer - University of Utah
|
February 2008
Topics
|
1. Clinical Topic:
|
Evaluation of rectal bleeding in adults |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were all of the realistic clinical strategies compared?
- Were all clinically relevant outcomes considered?
- Was an explicit and sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was potential impact of any uncertainty in the evidence determined in the baseline analysis?
- Does one strategy result in a clinically important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncertainty in the evidence change the results?
- Do the probabilty estimates fit my patients' clinical features?
- Do the utilities reflect how my patietns would value the outcomes of the decision?
- State the conclusion. Have the authors addressed the clinical question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Evaluation of rectal bleeding in adults; Allen E, Nicolaidis C, Helfand M; The Evaluation of Rectal Bleeding in Adults. A cost-effectiveness Analysis Comparing Four Diagnostic Strategies. JGen Intern Med 2005; 20: 81-90 |
2. How to use a clinical decision analysis (a); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(16): 1292-95 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(20): 1610-1613 |
| | | Reviews |
|
Clinical Review (Can):
|
Paul Johnson - Dalhousie University
|
|
Clinical Review (US):
|
George Chang - University of Texas M.D. Anderson Cancer Center
|
|
Methodological Review:
|
Mark Taylor - Lakeridge Health Centre
|
January 2008
Topics
|
1. Clinical Topic:
|
Fast track surgery |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the review explicitly address a sensible clinical question?
- Was the search for relelvant studies detailed and exhaustive?
- Were the primary studies of high methodologic quality?
- Were assessments of studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the review?
- How precise were the results?
- Were the clinically important outcomes considered?
- Are the benefits worth the costs and potential risks?
- State the conclusion. Have the authors addressed the clinical question?
- Does the evidence suppport the conclusion?
|
|
Articles
|
1. Fast track surgery; Wind J, Polle SW, Fung Kon Jin PHP, et al; Systematic review of enhanced recovery programmes in colonic surgery. Br. J. Surg 2006; 93: 800-09 |
2. How to use a systematic review and meta-analysis; Bhandari M, Devereaux PJ, Montore V, et al; for the Evidence Based Surgery Working Group. Users’ Guide to Surgical Literature: How to Use a Systematic Review and Meta-analysis. CJS 2004; 47(1): 60-67 |
| | | Reviews |
|
Clinical Review (Can):
|
Zane Cohen - University of Toronto
|
|
Clinical Review (US):
|
Anthony Senagore - Michigan State University
|
|
Methodological Review:
|
Tara Mastracci - McMaster University
|
December 2007
Topics
|
1. Clinical Topic:
|
Perioperative chemotherapy vs. surgery alone for gastric ca |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considere?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the clinical question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Perioperative chemotherapy vs. surgery alone for gastic ca; Cunningham D, Allum WH, Stenning SP, et al; Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. NEJM 2006; 355 (1): 11-20 |
2. How to use an article about therapy or prevention (a); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1993 Dec 1; 270(21): 2598-2601 |
3. How to use an article about therapy or prevention (b); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1994 Jan 5; 271(1): 59-63 |
| | | Reviews |
|
Clinical Review (Can):
|
Rick Malthaner - University of Western Ontario
|
|
Clinical Review (US):
|
Carlton Barnett - Unviersity of Texas
|
|
Methodological Review:
|
Harry Henteleff - Dalhousie University
|
November 2007
Topics
|
1. Clinical Topic:
|
Watch full waiting vs. hernia repair in minimally symptomatic men |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusion?
- Were patients, their clinicans and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental interventions, were the groups treated equally?
- How large and precise was the treatment effect? Calculate 95% CI around the difference in 30 day mortatliy rates between groups.
- State the estimates upon which the sample size was calculated. In retrospect, were they accurate?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the clinical question?
- Doses the evidence support the conclusion?
|
|
Articles
|
1. Watchful waiting vs. hernia repair in minimally symptomatic men; Fitzgibbons R, Hurder-Giobbie A, Gibbs JO, et al; Watchful Waiting vs. Repair of Inguinal Hernia in Minimally Symptomatic Men. A Randomized Clinical Trial. JAMA 2006; 295: 285-292 |
2. Measures of precision (confidence intervals); Montori V, Klienbart J, Newman T, et al, for the Evidence Based Medicine Teaching Tips Working Group. Tips for learners of Evidence-based medicine: 2. Measures of precision (confidence intervals) CMAJ 2004;171(6):611-15 |
| | | Reviews |
|
Clinical Review (Can):
|
Bill Fitzgerald - Charles S. Curtis Memorial Hospital
|
|
Clinical Review (US):
|
Demetrius Litwin - University of Massachusetts
|
|
Methodological Review:
|
Jeffrey Barkun - McGill University
|
October 2007
Topics
|
1. Clinical Topic:
|
Factor VIIa as adjuvent therapy for bleeding in trauma patients |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considere?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the clinical question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Factor VII as adjuvent therapy for bleeding in trauma patients; Boffard DK, Riou B, Warren B et al, for the NovoSeven Trauma Study Group. Recombinant Factor VIIa Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials. Journal of Trauma 2005; 59(1): 8-18 |
2. How to use an article about therapy or prevention (a); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1993 Dec 1; 270(21): 2598-2601 |
3. How to use an article about therapy or prevention (b);
Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1994 Jan 5; 271(1): 59-63 |
| | | Reviews |
|
Clinical Review (Can):
|
John Drover - Queens University
|
|
Clinical Review (US):
|
Brent Eastman - University of California, San Diego
|
|
Methodological Review:
|
Karen Brasel - Medical College of Wisconsin
|
May 2007
Topics
|
1. Clinical Topic:
|
SLNB in early stage breast cancer |
|
2. Methodological Topic:
|
Guidelines |
| |
|
Questions
|
- What is the clinical question being asked?
- Were all important otpions and outcomes considered?
- Was an explicit and sensible process used to identify, select and combine evidence?
- Was an explicit and sensible process used to consider the relative value of different outcomes?
- Is the guideline likely to account for important recent developments?
- Has the guideline been subjected to peer review and testing?
- Are practical clinically important recommendations made?
- How strong are the recommendations?
- What is the impact of uncertainty associated with the evidence and values used in the guidelines?
- Is the primary objective of the guidelines consistent with your objectives?
- Are the recommendations applicable to your patients?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. ASCO guideline recommendations for sentinel lymph node biopsy in early stage breast cancer; Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early Stage Breast Cancer. JCO 2005;23(30):7703-20 |
2. How to use clinical practice guidelines (a); Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to use Clinical Practice Guidelines. JAMA 1995;274(7):570-74 |
3. How to use clinical practice guidelines (b); Wilson MC, Hayward RSA, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to Use Clinical Practice Guidelines. JAMA 1995;274(20):1630-32 |
| | | Reviews |
|
Clinical Review (Can):
|
Sarkis Meterissian - McGill University
|
|
Clinical Review (US):
|
Kelly McMasters - University of Louisville
|
|
Methodological Review:
|
Leigh Neumayer - University of Utah
|
April 2007
Topics
|
1. Clinical Topic:
|
CT colonography vs. colonoscopy for colon cancer screening |
|
2. Methodological Topic:
|
Economic Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the anlaysis provide a full economic comparison of health care strategies?
- Was a broad enough viewpoint adopted?
- Were all the relevant clinical strategies compared?
- Were the costs and outcomes properly measured and valued?
- Was clinical effectiveness established?
- Were costs measured accurately?
- Were data on costs and outcomes appropriately integrated?
- Was appropriate allowance made for uncertainties in the analysis?
- What were the incremental costs and outcomes of each stategy?
- Do incremental costs and outcomes differ between subgroups?
- Could my patients expect similar health outcomes?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Cost effectiveness of CT colonography vs. colonoscopy for colorectal cancer screening; Heitman SJ, Manns BJ, Hilsden RJ, et al. Cost-Effectiveness of Computerized Tomographic Colonography versus Colonoscopy for Colorectal Cancer Screening. CMAJ 2005;173(8):877-81 |
2. How to use an article on economic analysis; Thoma A, Sprague S, Tandan V; for the Evidence-Based Surgery Working Group Users’ Guide to the Surgical Literature: How to Use an Article on Economic Analysis. CJS 2001;44(5):347-54 |
| | | Reviews |
|
Clinical Review (Can):
|
Nancy Baxter - University of Toronto
|
|
Clinical Review (Can):
|
Linda Rabeneck - University of Toronto
|
|
Clinical Review (Can):
|
Tanya Chawla - University of Toronto
|
|
Clinical Review (US):
|
James Church - Cleveland Clinic
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
March 2007
Topics
|
1. Clinical Topic:
|
MRI & Mammogram for breast cancer screening |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being addressed?
- What diagnostic tests are being compared?
- Did the study sample include an appropriate spectrum of patients?
- Did the results of one test influence the decision to perform the others?
- Are the methods for performing the test described in sufficient detail to permit replication?
- Comment on the test characteristics and calculate the likelihood ratios for each test.
- Will the reproducibility of the test results and their interpretation be satisfactory in my setting?
- Should MRI be used to screen high risk patients or is further evaluation required?
- Are the benefits and harms discussed adequately?
- Does cost-effectiveness need to be addressed?
- Do patient's values and preferences need to be considered?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Efficacy of MRI and mammogram for breast cancer screening in woman with familial or genetic predisposition; Kriege M, Brekelmans CTM, Boetes C, et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with Familial or Genetic Predisposition. NEJM 2004;351(5):427-37 |
2. How to use an article about a diagnostic test; Archibald S, Bhandari M, Thoma A, for the Evidence-Based Surgery Working Group. Users’ Guides to the Surgical Literature: How to Use an Article about a Diagnostic Test. CJS 2001;44(1):17-23 |
| | | Reviews |
|
Clinical Review (Can):
|
Geoffrey Porter - Dalhousie University
|
|
Clinical Review (US):
|
Todd Tuttle - University of Minnesota
|
|
Methodological Review:
|
Steven Latosinsky - University of Manitoba
|
February 2007
Topics
|
1. Clinical Topic:
|
PET/CT in the mangement of pancreatic ca |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being addressed?
- Is there an independent, blind comparison with a reference standard?
- Does the study sample include an appropriate spectrum of patients to which the diagnostic test is to be applied?
- Do the results of the test being evaluated influence the decision to perform the reference standard result?
- Are the methods for performing the test described in sufficient detail to permit replication?
- Are likelihood ratios for the test result presented or is the data necessary for their calculation included?
- Will the reproducibility of the test result and its interpretation be satisfactory in my setting?
- Are the results applicable to my patient?
- Will the results change my management?
- Will the patients be better off as a result of the test?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. PET/CT influences on the management of resectable pancreatic cancer; Heinrich S, Goerres GW, Schäfer M, et al. Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and its Cost Effectiveness. Ann of Surg. 2005;242(2):235-43 |
2. How to use an article about a diagnostic test; Archibald S, Bhandari M, Thoma A, for the Evidence-Based Surgery Working Group. Users’ Guides to the Surgical Literature: How to Use an Article about a Diagnostic Test. CJS 2001;44(1):17-23 |
| | | Reviews |
|
Clinical Review (Can):
|
Garth Warnock - University of British Columbia
|
|
Clinical Review (US):
|
Keith Lillemoe - Indiana University
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
January 2007
Topics
|
1. Clinical Topic:
|
Treatment of asymptomatic gall stones |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were all of the relaistic clinical strategies compared?
- Were all clinically relevant outcomes considered?
- Was an explicit and sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was the potential impact of any uncertainty in the evidence determined in the baseline analysis?
- Does one strategy result in a clinically important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncertainty in the evidence change the results?
- Do the probability estimates fit my patients' clinical features?
- Do the utilities reflect how my patients would value the outcomes of the decision?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Small gall stones are associated with an increased risk of pancreatitis, is there a potential benefit of prophylactic cholecystectomy; Venneman NG, Buskens E, Besselink MGH, et al. Small Gall Stones are Associated with Increased Risk of Acute Pancreatitis: Potential Benefits of Prophylactic Cholecystectomy. Am J Gastro 2005;100(11):2540-50 |
2. How to use a clinical decision analysis (a); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(16): 1292-95 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995;273(20):1610-13 |
| | | Reviews |
|
Clinical Review (Can):
|
Michael Marcaccio - McMaster University
|
|
Clinical Review (US):
|
Nat Soper - Northwestern University
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
December 2006
Topics
|
1. Clinical Topic:
|
EVAR 1 trial |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusion?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect? Calculate 95% CI around the difference in 30day mortality rates between groups.
- State the estimates upon which the sample size was calculated. In retrospect, were they accurate?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Endovasculare aneurysm repair vs. open repair in patients with abdominal aortic aneurysm; EVAR Trial participants. Endovascular Aneurysm Repairs vs Open Repair in Patients with Abdominal AorticAneurysm (EVAR Trial 1): Randomised Controlled Trial. Lancet 2005;365:2179-86 |
2. Measures of precision (confidence intervals); Montori V, Klienbart J, Newman T, et al, for the Evidence Based Medicine Teaching Tips Working Group. Tips for learners of Evidence-based medicine: 2. Measures of precision (confidence intervals) CMAJ 2004;171(6):611-15 |
| | | Reviews |
|
Clinical Review (Can):
|
Paul Petrasek - University of Calgary
|
|
Clinical Review (US):
|
Julie Freischlag - John Hopkins School of Medicine
|
|
Methodological Review:
|
Tara Mastracci - McMaster University
|
November 2006
Topics
|
1. Clinical Topic:
|
Stapled hemorrhoidopexy vs conventional hemorrhoidectomy |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the review explicitly address a sensible clinical question?
- Was the search for relevant studies detailed and exhaustive?
- Were the primary studies of high methodologic quality?
- Were assessments of studies reproducable?
- Were the results similar from study to study?
- What are the oveall results of the review?
- How precise were the results?
- Were the clinically important outcomes considered?
- Are the benefits worth the costs and potential risks?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Stapled hemorrhoidopexy vs conventional hemorrhoidectomy; Nisar PJ, Acheson AG, Neal KR, et al. Stapled Hemorrhoidopexy Compared with Conventional Hemorrhoidectomy: Systematic Reviews of Randomized Controlled Trials. DCR 2004;47(11):1837-45 |
2. How to use a systematic review and meta-analysis; Bhandari M, Devereaux PJ, Montore V, et al; for the Evidence Based Surgery Working Group. Users’ Guide to Surgical Literature: How to Use a Systematic Review and Meta-analysis. CJS 2004; 47(1): 60-67 |
| | | Reviews |
|
Clinical Review (Can):
|
Marcus Burnstein - University of Toronto
|
|
Clinical Review (US):
|
Rob Madoff - University of Minnesota
|
|
Methodological Review:
|
Andy Kirkpatrick - University of Calgary
|
October 2006
Topics
|
1. Clinical Topic:
|
Surgical site infections |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considered?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Risk of surgical wound infections reduced with supplemental perioperative oxygen; Belda FJ, Aguilera L, García de la Asunción J, et al; Supplemental Perioperative Oxygen and the Risk of Surgical Wound Infection. A Randomized Controlled Trial. JAMA 2005;294(16):2035-42 |
2. How to use an article about evaluating surgical interventions; Urschel JD, Goldsmith CH, Tandan VR, Miller JD; for the Evidence-Based Surgery Working Group. Users’ Guide to Evidence-Based Surgery: How to Use an Article Evaluating Surgical Interventions CJS 2001; 44(2): 95-100 |
| | | Reviews |
|
Clinical Review (Can):
|
Donna McRitchie - University of Toronto
|
|
Clinical Review (US):
|
Patch Dellinger - University of Washington
|
|
Methodological Review:
|
Karen Brasel - Medical College of Wisconsin
|
May 2006
Topics
|
1. Clinical Topic:
|
Treatment of occult pneumothoraces from blunt trauma |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusion?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect? Calculate 95% CI around the difference in 30-day mortality rates between groups.
- State the estimates upon which the sample size was calculated. In retrospect, were they accurate?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion.
|
|
Articles
|
1. Treatment of occult pneumothoraces from blunt trauma; Brasel K, Stafford RE, Weigelt JA, et al; Treatment of Occult Pneumothoraces from Blunt Trauma. J Trauma 1999; 46(6): 987-91 |
2. Measures of precision (confidence intervals); Montori V, Klienbart J, Newman T, et al, for the Evidence Based Medicine Teaching Tips Working Group. Tips for learners of Evidence-based medicine: 2. Measures of precision (confidence intervals) CMAJ 2004; 171(6): 611-15 |
| | | Reviews |
|
Clinical Review (Can):
|
Mary van Wijngaarden-Stephens - University of Alberta
|
|
Clinical Review (US):
|
Timothy Fabian - University of Tennessee
|
|
Methodological Review:
|
Andy Kirkpatrick - University of Calgary
|
April 2006
Topics
|
1. Clinical Topic:
|
Prerandomization of surgical training for the NSABP B-32 trial |
|
2. Methodological Topic:
|
Knowledge Transfer |
| |
|
Questions
|
- Outline the training process used in the NSABP B-32 trial to teach sentinel node biopsy
- What outcomes were used to assess surgeon proficiency?
- Were the outcome measures clinically relevant?
- Do the results support the conclusion that "a large number of surgeons capable of performing sentinel lymph node biopsy in a standardized fashion with a high degree of protocol compliance and pathologic accuracy."?
- Is this training process applicable to transfer of new skills to practicing surgeons?
- Is learning new technical skills important to you in practice?
- What is the optimal method for you personally to learn new skills?
|
|
Articles
|
1. Prerandomization of surgical training for the NSABP B-32 trial; Harlow SP, Krag DN Julian TB, et al; Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial. A Ranomized Phase III Clinical Trial to compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer. Ann Surg 2005; 241(1): 48-54 |
2. Improving continuing medical education for surgical techniques; Rogers DA, Elstein AS, Bordage G; Improving Continuing Medical Education for Surgical Techniques: Applying the Lessons Learned in the First Decade of Minimal Access Surgery Ann of Surg 2001; 233(2): 159-66 |
| | | Reviews |
|
Clinical Review (Can):
|
Helen MacRae - University of Toronto
|
|
Clinical Review (US):
|
Marilyn Leitch - University of Texas
|
|
Methodological Review:
|
Leigh Neumayer - University of Utah
|
March 2006
Topics
|
1. Clinical Topic:
|
Validation of the American joint committee on cancer melanoma staging system |
|
2. Methodological Topic:
|
Prognosis/Natural History |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was there a representative and well-defined sample of patients at a similar point in the course of the disease?
- Was follow-up sufficiently long and complete?
- Were objective and unbiased outcome criteria used?
- Was there adjustment for important progostic factors?
- How large is the likelihood of the outcome event(s) in a specified period of time?
- How precise are the estimates of likelihood?
- Will the results help me in caring for my patients?
- Will the results lead directly to selecting or avoiding therapy?
- Are the results useful for reassuring or counselling patients?
- State the conclusion. Have the authors addressed the question?
- Does the the evidence support the conclusion?
|
|
Articles
|
1. Progostic factors analysis of 17,600 melanoma patients; Balch CM, Soong SJ, Gerdhenwoald J et al; Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 2001; 19(16): 3622-34 |
2. How to use an article about prognosis; Laupacis A, Wells G, Richardson WS, Tugwell P, for The Evidence-Based Working Group: Users' Guides to the Medical Literature. V. How to Use an Article About Prognosis. JAMA 1994; 272: 234-237 |
| | | Reviews |
|
Clinical Review (Can):
|
Ralph George - Queen's University
|
|
Clinical Review (US):
|
Philip Haigh - Kaiser Permanente Los Angeles Medical Center
|
|
Methodological Review:
|
Steven Latosinsky - University of Manitoba
|
February 2006
Topics
|
1. Clinical Topic:
|
Decision aids for patients considering options aftecting cancer outcomes |
|
2. Methodological Topic:
|
Decision Aid |
| |
|
Questions
|
- What is the objective of the decision aid?
- Is there a need for a decision aid?
- Were all treatment options considered in the decision aid and were they appropriate?
- What were the outcomes measured?
- Were the outcomes appropriate and complete?
- What is the conclusion?
- Does the evidence support the conclusion?
- Will the decision aid be useful in your practice?
|
|
Articles
|
1. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery; Whelan T, Levine M, Willan A, et al; Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery. A Randomized Trial. JAMA 2004; 292(4): 435-41 |
2. Decision aids for patients consdiering options affecting cancer outcomes; O’Connor AM, Fieset V, DeGrasse C, et al; Decision Aids for Patients Considering Options Affecting Cancer Outcomes: Evidence of Efficacy and Policy Implications Monogr Natl Cancer Inst 1999; 25: 67-80 (no link available) |
| | | Reviews |
|
Clinical Review (Can):
|
Dave McCready - University of Toronto
|
|
Clinical Review (US):
|
Armando Giuliano - University of California (LA)
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
January 2006
Topics
|
1. Clinical Topic:
|
Timing of elective colectomy in diverticulitis |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were all of the realistic clinical strategies compared?
- Were all clinically relevant outcomes consdiered?
- Was an explicit and sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was the potential impact of any uncertainty in the evidence determined in the baseline analysis?
- Does one stategy result in a clincally important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncertainty in the evidence change the results?
- Doe the probability estimates fit my patients' clinical features?
- Do the utlities reflect how my patients would value the outcomes of the decision?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Timing of elective colectomy in diverticulitis; Salem L, Veenstra D, Sullivan SD, Flum DR; The Timing of Elective Colectomy in Diverticulitis: A Decision Analysis. J Am Coll Surg 2004; 199(6): 904-12 |
2. How to use a clinical decision analysis (a); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(16): 1292-95 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(20): 1610-13 |
| | | Reviews |
|
Clinical Review (Can):
|
Terry Phang - University of British Columbia
|
|
Clinical Review (US):
|
Steve Wexner - Cleveland Clinic
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
December 2005
Topics
|
1. Clinical Topic:
|
Value of prohylactic drainage in GI surgery |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the review explicitly address a sensible clinical question?
- Was the search for relevant studies detailed and exhaustive?
- Were the primary studies of high methodologic quality?
- Were assessments of studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the review?
- How precise were the results?
- Were the clinically important outcomes considered?
- Are the benefits worth the costs and potential risks?
- State the conclusion. Have the authors addressed the question?
- Does the evidence suppport the conclusion?
|
|
Articles
|
1. Evidence based value of prophylactic drainage in GI surgery; Petrowsky H, Demartines N, Rolusson V, Clavien PA; Evidence-based Value of Prophylactic Drainage in Gastrointestinal Surgery. A Systematic Review and Meta-analysis. Ann Surg 2004; 240(6): 1074-85 |
2. How to use a systematic review and meta-analysis; Bhandari M, Devereaux PJ, Montore V, et al; for the Evidence Based Surgery Working Group. Users’ Guide to Surgical Literature: How to Use a Systematic Review and Meta-analysis. CJS 2004; 47(1): 60-67 |
| | | Reviews |
|
Clinical Review (Can):
|
Bill Fitzgerald - St. Anthony NL
|
|
Clinical Review (US):
|
Michael Sarr - Mayo Clinic College of Medicine
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
November 2005
Topics
|
1. Clinical Topic:
|
Lap. assisted colectomy vs. open colectomy for colon ca |
|
2. Methodological Topic:
|
Quality of Life |
| |
|
Questions
|
- What is the clinical question being addressed?
- Have the investigators measured aspects of patients' lives that patients consider important?
- Did the HRQL Instruments work in the way they are supposed to?
- Are there important aspects of HRQL that have been omitted?
- If there were trade-offs between quality and quantity of life, or an economic evaluation, have the investigators used the right measures?
- What was the magnitude of effect on HRQL?
- Will the information from the study help me inform my patients?
- Did the study design simulate clinical practice?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Quality of life outcomes following laparoscopic assisted colectomy vs. open colectomy for colon cancer; Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G, for the Clinical Outcomes of Surgical Therapy (COST) Study Group. Short-term Quality-of-Life Outcomes Following Laparoscopic-Assisted Colectomy vs. Open Colectomy for Colon Cancer. A Randomized Trial. JAMA 2002; 287(3): 321-328 |
2. How to use articles about health related quality of life; Guyatt, GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ, for the Evidence-Based Medicine Working Group: Users’ Guide to the Medical Literature. XII. How to Use Articles About Health-Related Quality of Life. JAMA 1997; 277(15):1232-37 |
| | | Reviews |
|
Clinical Review (Can):
|
Don Buie - University of Calgary
|
|
Clinical Review (US):
|
Jim Fleshman - University of Washington
|
|
Methodological Review:
|
Karen Brasel - Medical College of Wisconsin
|
October 2005
Topics
|
1. Clinical Topic:
|
Primary hyperparathyroidism |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considered?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
-
|
|
Articles
|
1. Mild asymptomatic primary hyperparathryoidism; Talpos GB, Bone III HG, Kleerekoper M, et al; Randomized Trial of Parathyroidectomy in Mild Asymptomatic Primary Hyperparathyroidism: Patient Description and Effects on the SF-36 Health Survey. Surgery 2000; 128: 1031-21 |
2. How to use an article evaluating surgical interventions; Urshel JD, Goldsmith CH, Tandan VR, Miller JD; for the Evidence-Based Surgery Working Group. Users’ Guide to Evidence-Based Surgery: How to Use an Article Evaluating Surgical Interventions. CJS 2001; 44(2): 95-100 |
| | | Reviews |
|
Clinical Review (Can):
|
Sam Wiseman - University of British Columbia
|
|
Clinical Review (US):
|
Quan-Yong Duh - Ujniversity of California (San Francisco)
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
May 2005
Topics
|
1. Clinical Topic:
|
Fibrin glue vs. conventional treatment for anal fistula |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusion?
- Was there adequate blinding of patients, their clinicians and study personnel?
- Were the groups similar at the start of the trial?
- Was there adequate standardization of the surgical procedure?
- How large and precise was the treatment effect?
- Are the procedures adequately described so that they can be used in your own patient care?
- Are the surgical techniques that were compared still relevant or have they been supplanted by newer procedures?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. The use of fibrin glue vs. conventional treatment for anal fistula; Lindsey I, Smilgin-Humphreys MM, Cunningham C, et al; A Randomized, Controlled Trial of Fibrin Glue vs. Conventional Treatment for Anal Fistula. DCR 2002; 45 (12): 1608-15 |
2. Issues in surgical randomized controlled trials; McLeod, RS: Issues in Surgical Randomized Controlled Trials. World J. Surg 1999; 23: 1210-1214
* You may want to refer to the methodology article on treatment effectiveness from the Oct. 2004 package |
| | | Reviews |
|
Clinical Review (Can):
|
Bernie McIntyre - Dalhousie University
|
|
Clinical Review (US):
|
David Schoetz - Tufts University
|
|
Methodological Review:
|
Andy Kirkpatrick - University of Calgary
|
April 2005
Topics
|
1. Clinical Topic:
|
Barrett's esophagus |
|
2. Methodological Topic:
|
Prognosis/Natural History |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was there a representive and well-defined sample of patients at a similar point int he course of the disease?
- Was follow-up sufficiently long and complete?
- Were objective and unbiased outcome criteria used?
- Was there adjustment for important prognostic factors?
- How large is the likelihood of the outcome event(s) in a specified period of time?
- How precise are the estimates of likelihood?
- Will the results help me in caring for my patients?
- Will the results lead directly to selecting or avoiding therapy?
- Are the results useful for reassuring or counseling patients?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Mortality in Barrett's esophagus; Anderson LA, Murray LJ, Murphy SJ, et al; Mortality in Barrett’s Oesophagus: Results from a Population Based Study. Gut 2003; 52: 1081-84 (no link available) |
2. How to use an article about prognosis; Laupacis A, Wells G, Richardson WS, Tugwell P, for The Evidence-Based Working Group: Users' Guides to the Medical Literature. V. How to Use an Article About Prognosis. JAMA 1994; 272: 234-237 |
| | | Reviews |
|
Clinical Review (Can):
|
Larry Tan - University of Manitoba
|
|
Clinical Review (US):
|
Jeffrey Peters - University of Rochester School of Medicine and Dentistry
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
March 2005
Topics
|
1. Clinical Topic:
|
Morbid obesity |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were all the realistic clinical strategies compared?
- Were all clinically relevant outcomes considered?
- Was an explicit and sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was the potential impact of any uncertainty in the evidence determined in the baseline analysis?
- Does one strategy result in a clinically important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncetainty in the evidence change the results?
- Do probability estimates fit my patient's clinical features?
- Do the utilities reflect how my patients would value the outcomes of the decision?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Comparison of diet and exercise vs. gastric bypass surgery for morbid obesity; Patterson EJ, Urbach DR, Swanstrom LL; A Comparison of Diet and Exercise Therapy Versus Laparoscopic Roux-en-Y Gastric Bypass Surgery for Morbid Obesity: A Decision Analysis Model. J Am Coll Surg 2003; 196 (3): 379-84 |
2. How to use a clinical decision analysis (a); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(16): 1292-95 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(20): 1610-13 |
| | | Reviews |
|
Clinical Review (Can):
|
Dave Pace - Memorial University
|
|
Clinical Review (Can):
|
Barbara Bass - University of Maryland
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
February 2005
Topics
|
1. Clinical Topic:
|
Hepatic metastasectomy |
|
2. Methodological Topic:
|
Economic Analysis |
| |
|
Questions
|
- What is the clincial question being addressed?
- Did the analysis provide a full economic comparison of health care strategies?
- Was a broad enough viewpoint adopted?
- Were all the relevant clinical strategies compared?
- Were the costs and outcomes properly measured and valued?
- Was clinical effectiveness established?
- Were costs measured accurately?
- Were data on costs and outcomes appropriately integrated?
- Was appropriate allowance made for uncertainties in the analysis?
- What were the incremental costs and outcomes of each strategy?
- Do increments costs and outcomes differ between subgroups?
- Could my patients expect similar health outcomes?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Cost effectiveness of hepatic metastasectomy in patients with meatastatic colorectal cancer; Gazelle GS, Hunink MGM, Kuntz KM, et al; Cost-Effectiveness of Hepatic Metastasectomy in Patients with Metastatic Colorectal Carcinoma. Annals of Surgery 2003; 237 (4): 544-55 |
2. How to use an article on economic analysis (a); Drummond MF, Richardson WS, O'Brien BJ, et al, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. XIII. How to Use an Article on Economic Analysis. JAMA 1997; 277(19): 1552-1557 |
3. How to use an article about economic analysis (b); O'Brein BJ, Heyland D, Richardson WS, et al, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. XIII. How to Use an Article on Economic Analysis. JAMA 1997; 277(22): 1802-1806 |
| | | Reviews |
|
Clinical Review (Can):
|
Sharif Hannah - University of Toronto
|
|
Clinical Review (US):
|
Yuman Fong - Cornell University
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
January 2005
Topics
|
1. Clinical Topic:
|
CT mesenteric ischemia |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being addressed?
- Is there an independent, blind comparison with a reference standard?
- Does the study sample include an appropriate spectrum of patients to which the diagnostic test is applied?
- Do the results of the test being evaluated influence the decision to perform the reference standard test?
- Are the methods for performing the test described in sufficient detail to permit replication?
- Are likelihood ratios for the test results presented, or is the data necessary for their calculation included?
- Will the reproducibility of the test result and its interpretation be satisfactory in my setting?
- Are the results applicable to my patient?
- Will the results change my management?
- Will patients be better off as a result of the test?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Biphasic CT with mesenteric CT angiography in the evaluation of acute mesenteric ischemia; Kirkpatrick IDC, Kroeker MA, Greenberg HM; Biphasic CT with Mesenteric CT Angiography in the Evaluation of Acute Mesenteric Ischemia: Initial Experience. Radiology 2003; 229 (1): 91-98 (no link available) |
2. How to use an artcile about a diagnostic test; Archibald S, Bhandari M, Thoma A, for the Evidence-Based Surgery Working Group. Users’ Guides to the Surgical Literature: How to Use an Article about a Diagnostic Test. CJS 2001; 44(1): 17-23 |
| | | Reviews |
|
Clinical Review (Can):
|
Tom Lindsay - University of Toronto
|
|
Clinical Review (Can):
|
Martin O'Malley - University of Toronto
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
December 2004
Topics
|
1. Clinical Topic:
|
Screening mammography |
|
2. Methodological Topic:
|
Guidelines |
| |
|
Questions
|
- What is the clinical question being asked?
- Were all important options and outcomes considered?
- Was an explicit and sensible process used to identify, select and combine evidence?
- Was an explicit and sensible process used to consider the relative value of different outcomes?
- Is the guideline likely to account for important recent developments?
- Has the guideline been subjected to peer review and testing?
- Are practical clinically important recommendations made?
- How strong are the recommendations?
- What is the impact of uncertainty associated with the evidence and values used in the guidelines?
- Is the primary objective of the guidelines consistent with your objective?
- Are the recommendations applicable to your patients?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Screening mammorgraphy among women aged 40-49 years at average risk for breast ca; Ringash J, with the Canadian Task Force on Preventive Health Care; Preventive Health Care, 2001 Update: Screening Mammography Among Women Aged 40-49 years at Average Risk of Breast Cancer. CMAJ 2001; 164 (4): 469-76 |
2. How to use clinical practice guidelines (a); Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to use Clinical Practice Guidelines. JAMA 1995;274(7): 570-74 |
3. How to use clinical practice guidelines (b); Wilson MC, Hayward RSA, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to Use Clinical Practice Guidelines. JAMA 1995; 274(20):1630-32 |
| | | Reviews |
|
Clinical Review (Can):
|
Carman Ciacomantonio - Dalhousie University
|
|
Clinical Review (US):
|
Kelly Hunt - University of Texas
|
|
Methodological Review:
|
Steven Latosinsky - University of Manitoba
|
November 2004
Topics
|
1. Clinical Topic:
|
Preoperative fasting |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the review explicitly address a sensible clinical question?
- Was the search for relevant studies detailed and exhaustive?
- Were the primary studies of high methodologic quality?
- Were the assessments of studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the review?
- How precise were the results?
- Were the clinically important outcomes considered?
- Are the benefits worth the costs and potential risks?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Preoperative fasting for adults to prevent perioperative complications; Brady M, Kinn S, Stuart P; Preoperative Fasting for Adults to Prevent Perioperative Complications. The Cochrane Library Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd. (no link available) |
2. How to use a systematic review and meta-analysis; Bhandari M, Devereaux PJ, Montore V, et al; for the Evidence Based Surgery Working Group. Users’ Guide to Surgical Literature: How to Use a Systematic Review and Meta-analysis. CJS 2004; 47(1): 60-67 |
| | | Reviews |
|
Clinical Review (Can):
|
Bill Fitzgerald - St. Anthony NL
|
|
Clinical Review (US):
|
Michael Sarr - Mayo Clinic College of Medicine
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
October 2004
Topics
|
1. Clinical Topic:
|
Bile duct stones |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considered?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Wait & see policy or laparoscopic cholecystecomy after endoscopic sphincterotomy for bile duct stones; Boerma D, Bauws EJ, Keulemans YA et al; Wait-and-See Policy or Laparoscopic Cholecystectomy after Endoscopic Sphincterotomy for Bile-Duct Stones: A Randomised Trial. Lancet 2002; 360: 761-65 |
2. How to use an article about evaluating surgical interventions; Urschel JD, Goldsmith CH, Tandan VR, Miller JD; for the Evidence-Based Surgery Working Group. Users’ Guide to Evidence-Based Surgery: How to Use an Article Evaluating Surgical Interventions CJS 2001; 44(2): 95-100 |
| | | Reviews |
|
Clinical Review (Can):
|
Elijah Dixon - University of Calgary
|
|
Clinical Review (US):
|
Steve Strasberg - Washington School of Medicine
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
May 2004
Topics
|
1. Clinical Topic:
|
Peripheral vascular disease |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were all of the realistic clinical strategies compared?
- Were all clinically relevant outcomes considered?
- Was an explicit and sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was the potential impact of any uncertainty in the evidence determined in the baseline analysis?
- Does one strategy result in a clinically important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncertainty in the evidence change the results?
- Do the probability estimates fit my patients' clinical features?
- Do the utilities reflect how my patients would value the outcomes of the decision?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. The effect of perioperative aspirin therapy in peripheral vascular surgery; Neilipovitz DT, Bryson GL, Nichol G, The Effect of Perioperative Aspirin Therapy in Peripheral Vascular Surgery: a Decision Analysis. Anesth Analg. 2001; 93: 573-80 (no link available) |
2. How to use a clinical decision analysis (a); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(16): 1292-95 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(20): 1610-13 |
| | | Reviews |
|
Clinical Review (Can):
|
George Louridas - University of Manitoba
|
|
Methodological Review:
|
Claudio Cina - McMaster University
|
April 2004
Topics
|
1. Clinical Topic:
|
Splenic trauma |
|
2. Methodological Topic:
|
Guidelines |
| |
|
Questions
|
|
What impact (negative or positive) did the following factors have in the implementation of the clinical practice guidelines (CPGs) on the Management of Pediatric Splenic Trauma:
- The strength of the evidence used to develop and maintain the CPGs?
- The technological advancements utilized to develop and maintain the CPGs?
- The technological advancements utilized to implement the CPGs?
- Information sharing and cooperation amongst groups developing CPGs on the same topic?
- Involvement of different stakeholders in the development and implementation of CPGs?
- The use of report cards or disincentives to increase compliance with CPGs?
- Use of CPGs to restrict legitimate health care choices or limit health care costs?
|
|
Articles
|
1. Compliance with Evidence-based guidelines in children with isolated spleen or liver injury; Stylianos S and the APSA Liver/Spleen Trauma Study Group. Compliance with Evidence-Based Guidelines in Children with Isolated Spleen or Liver Injury: A Prospective Study. J Pediatr Surg 2002; 37(3): 453-56 (no link available) |
2. Evidence-based guidelines for resource utilization in children with isolated spleen or liver injury; Stylianos S and the APSA Liver/Spleen Trauma Study Group. Evidence-Based Guidelines for Resource Utilization in Children with Isolated Spleen or Liver Injury. J Pediatr Surg 2000; 35(2): 164-69 (no link available) |
3. Imporving clinical practice guidelines for the 21st century; Browman, GP. Improving Clinical Practice Guidelines for the 21st Century. Intl J of Technology Assessment in Health Care 2000; 16(4): 959-68 (no link available) |
| | | Reviews |
|
Clinical Review (Can):
|
Eric Webber - University of British Columbia
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
March 2004
Topics
|
1. Clinical Topic:
|
Gastric ca |
|
2. Methodological Topic:
|
Guidelines |
| |
|
Questions
|
- What is the clinical question being asked?
- Were all important options and outcomes considered?
- Was an explicit and sensible process used to identify, select and combine evidence?
- Was an explicit and sensible process used to consider the relative value of different outcomes?
- Is the guideline likely to account for important recent developments? Has the guideline been subjected to peer review and testing?
- Are practical clinically important recommendations made?
- How strong are the recommendations?
- What is the impact of uncertainty associated with the evidence and values used in the guidelines?
- Are the recommendations applicable to your patients?
|
|
Articles
|
1. Neoadjuvant or adjuvant therapy for resectable gastric cancer; Earle CC, Maroun J, Zuraw L, et al: Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer? A Practice Guideline. Can J Surg. 2002; 45(6): 438-48 |
2. How to use clinical practice guidelines (a); Earle CC, Maroun J, Zuraw L, et al: Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer? A Practice Guideline. Can J Surg. 2002; 45(6): 438-48 |
3. How to use clinical practice guidelines (b); Wilson MC, Hayward RSA, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to Use Clinical Practice Guidelines. JAMA 1995; 274(20):1630-32 |
| | | Reviews |
|
Clinical Review (Can):
|
Debra Wirtzfeld - Memorial University
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
February 2004
Topics
|
1. Clinical Topic:
|
Penetrating colon injuries |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- What were the criteria used to select articles for inclusion
- Is it unlikely that important relevant studies were missed?
- Was the validity of the included studies appraised?
- Were assessments of the studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the overview? How precise were the results?
- Were all clinically important outcomes considered?
- Are the benefits worth the harms and costs?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Primary repair for penetrating colon injuries; Nelson R, Singer M: Primary Repair for Penetrating Colon Injuries (Cochrane Review). The Cochrane Library 2003; Issue (1) (no link available) |
2. How to use an overview; Oxman AD, Cook DJ, Guyatt GH, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. VI. How to Use an Overview. JAMA 1994; 272: 1367-71 |
| | | Reviews |
|
Clinical Review (Can):
|
Sarvesh Logsetty - University of Alberta
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
January 2004
Topics
|
1. Clinical Topic:
|
Adenocarcinoma esophagus |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question?
- Is the evidence strong enough to conclude that the outcome is similar irrespective of the type of surgical procedure in patients with adenocarcinoma of the esophagus?
|
|
Articles
|
1. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma; Hulscher JBF, Van Sandick JW, De Boer AGEM, et al: Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus. N Engl J Med 2002; 347(21): 1662-69 |
2. Interpreting study results: confidence intervals; Guyatt G, Jaeschke R, Heddle N, Cook D, Shannon H, Walter S: Basic Statistics for Clinicians: Interpreting Study Results: Confidence Intervals. Can Med Assoc J 1995; 152 (2): 169-173 |
| | | Reviews |
|
Clinical Review (Can):
|
Denise Ouellette - University of Montreal
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
December 2003
Topics
|
1. Clinical Topic:
|
Colon ca |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considered?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Laparoscopic assisted colectomy vs. open colectomy for treatment of non-metastatic colon cancer; Lacy AM, Garcia-Valdecasas JC, Delgado S, et al: Laparoscopy-Assisted Colectomy Versus Open Colectomy for Treatment of Non-Metastatic Colon Cancer: a Randomised Trial. Lancet 2002; 359: 2224-29 |
2. How to use an article evaluating surgical interventions; Urschel JD, Goldsmith CH, Tandan VR, Miller JD; for the Evidence-Based Surgery Working Group. Users’ Guide to Evidence-Based Surgery: How to Use an Article Evaluating Surgical Interventions CJS 2001; 44(2): 95-100 |
| | | Reviews |
|
Clinical Review (Can):
|
Hartley Stern - University of Ottawa
|
|
Methodological Review:
|
Carole Richard - University of Montreal
|
November 2003
Topics
|
1. Clinical Topic:
|
MRCP |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being addressed?
- Is there an independent, blind comparison with a reference standard?
- Does the study sample include an appropriate spectrum of patients to which the diagnostic test is to be applied?
- Do the results of the test being evaluated influence the decision to perform the reference standard test?
- Are the methods for performing the test described in sufficient detail to permit replication?
- Are likelihood ratios for the test results presented, or is the data necessary for their calculation included?
- Will the reproducibility of the test result and its interpretation be satisfactory in my setting?
- Are the results applicable to my patient?
- Will the results change my management?
- Will patients be better off as a result of the test?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Efficacy of Diagnosis of Mechanical Cholestatsis by MRC; Urban M, Holzer B, Sebesta C, et al: Efficacy of Diagnosis of Mechanical Cholestatsis by Magnetic Resonance Cholangiography. World J. Surg. 2002; 26: 353-58 |
2. How to use an artcile about a diagnostic test; Archibald S, Bhandari M, Thoma A, for the Evidence-Based Surgery Working Group. Users’ Guides to the Surgical Literature: How to Use an Article about a Diagnostic Test. CJS 2001; 44(1): 17-23 |
| | | Reviews |
|
Clinical Review (Can):
|
Elijah Dixon - University of Calgary
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
October 2003
Topics
|
1. Clinical Topic:
|
Retained sponges |
|
2. Methodological Topic:
|
Causation/Risk Factors |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were there clearly identified comparison groups that were similar with respect to important determinants of outcome other than the one of interest?
- Were the exposures and outcomes measured in the same way in the groups being compared?
- Was follow-up sufficiently long and complete?
- Is the temporal relationship correct?
- Is there a dose-response gradient?
- How strong is the association between exposure and outcome?
- How precise is the estimate of the risk?
- Are the results applicable to my practice?
- What is the magnitude of the risk?
- Should I attempt to stop the exposure?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
- Can the results of this study lead to improved outcome in your setting?
|
|
Articles
|
1. Risk factors for retained sponges after surgery; Gawande AA, Studdert DM, Orav EJ, et al: Risk Factors for Retained Instruments and Sponges after Surgery. N Engl J Med 2003;348:229-35 |
2. How to use an article about harm; Mitchell L, Walter S, Lee H, Haines T, Holbrook A, Moyer V, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. IV. How to Use an Article about Harm. JAMA 1994; 271(20): 1615-19 |
| | | Reviews |
|
Clinical Review (Can):
|
John Bohnen - University of Toronto
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
May 2003
Topics
|
1. Clinical Topic:
|
Common bile duct injury |
|
2. Methodological Topic:
|
Quality of Life |
| |
|
Questions
|
- What is the clinical question being addressed?
- Have the investigators measured aspects of patients' lives that patients consider important?
- Did the HRQL Instruments work in the way they are supposed to?
- Are there important aspects of HRQL that have been omitted?
- If there were trade-offs between quality and quantity of life, or an economic evaluation, have the investigators used the right measures?
- What was the magnitude of effect on HRQL?
- Will the information from the study help me inform my patients?
- Did the study design simulate clinical practice?
- State the conclusion. Have the authors addressed the question posed?
|
|
Articles
|
1. Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy; Boermaa D, Rauws EA, Keulemans YCA et al. Impaired Quality of Life 5 Years After Bile Duct Injury During Laparoscopic Cholecystectomy. Annals of Surgery 2001; 234(6): 750-7 |
2. Outcome research: what to measure; Wright JG: Outcomes Research: What to Measure. World J Surg. 1999;23:1224-26 |
3. How to use articles about health related quality of life; Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ, for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. XII. How to Use Articles About Health-Related Quality of Life. JAMA 1997; 277 (15): 1232-1237 |
| | | Reviews |
|
Clinical Review (Can):
|
Richard Hart - University of Toronto
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
April 2003
Topics
|
1. Clinical Topic:
|
Esophageal Ca |
|
2. Methodological Topic:
|
Causation/Risk Factors |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were there clearly identified comparison groups that were similar with respect to important determinants of outcome other than the one of interest?
- Were the exposures and outcomes measured in the same way in the groups being compared?
- Was follow-up sufficiently long and complete?
- Is the temporal relationship correct?
- Is there a dose-response gradient?
- How strong is the association between exposure and outcome?
- How precise is the estimate of the risk?
- Are the results applicable to my practice?
- What is the magnitude of the risk?
- Should I attempt to stop the exposure?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma; Lagergren J, Bergstrom R, Lindgren A, Nyrén O. Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma. NEJM 1999; 340(11): 825-31 |
2. How to use an article about harm; Mitchell L, Walter S, Lee H, Haines T, Holbrook A, Moyer V, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. IV. How to Use an Article about Harm. JAMA 1994; 271(20): 1615-1619 |
| | | Reviews |
|
Clinical Review (Can):
|
Gail Darling - University of Toronto
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
March 2003
Topics
|
1. Clinical Topic:
|
Bowel Prep |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- What were the criteria used to select articles for inclusion
- Is it unlikely that important relevant studies were missed?
- Was the validity of the included studies appraised?
- Were assessments of the studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the overview? How precise were the results?
- Were all clinically important outcomes considered?
- Are the benefits worth the harms and costs?
- State the conclusion. Have the authors’ addressed the question posed? Does the evidence support the conclusion?
|
|
Articles
|
1. Preoperative bowel cleansing; Guenaga KF. Preoperative Bowel Cleansing. Seminars in Colon & Rectal Surgery. 2002; 13(1): 53-61 (link not available) |
2. How to use an overview; Oxman AD, Cook DJ, Guyatt GH, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. VI. How to Use an Overview. JAMA 1994; 272: 1367-1371 |
| | | Reviews |
|
Clinical Review (Can):
|
Ben Yip - University of Manitoba
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
February 2003
Topics
|
1. Clinical Topic:
|
Hospital volume and surgical mortatlity |
|
2. Methodological Topic:
|
Health Services Research |
| |
|
Questions
|
- What is the clinical question being addressed?
- How accurate is the database?
- How were the volume groups determined?
- Is the primary outcome measure appropriate?
- How do patients compare among volume groups and were differences considered in the analysis?
- What was the magnitude of the results?
- How precise was the estimate of the treatment effect?
- Will the results help me?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Hospital volume and surgical mortality; Birkmeyer JD, Siewers AE, Finlayson EVA, et al: Hospital Volume and Surgical Mortality in the United States. NEJM 2002; 346(15): 1128-37 |
2. How to use an article reporting population based volume-outcome relationships in surgery; Hong D, Tandan VR, Goldsmith CH, Simunovic M, for the Evidence-Based Surgery Working Group. Users' Guide to the Surgical Literature: How to Use an Article Reporting Population Based Volume-Outcome Relationships in Surgery. CJS 2002; 45(2): 109-15 |
| | | Reviews |
|
Clinical Review (Can):
|
Donna Maziak - University of Ottawa
|
|
Methodological Review:
|
Claudio Cina - McMaster University
|
January 2003
Topics
|
1. Clinical Topic:
|
DCIS/Breast ca |
|
2. Methodological Topic:
|
Guidelines |
| |
|
Questions
|
- What is the clinical question being asked?
- Were all important options and outcomes considered?
- Was an explicit and sensible process used to identify, select and combine evidence?
- Was an explicit and sensible process used to consider the relative value of different outcomes?
- Is the guideline likely to account for important recent developments? Has the guideline been subjected to peer review and testing?
- Are practical clinically important recommendations made?
- How strong are the recommendations?
- What is the impact of uncertainty associated with the evidence and values used in the guidelines?
- Are the recommendations applicable to your patients?
|
|
Articles
|
1. Clinical practice guidelines for breast cancer; The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: The Management of Ductal Carcinoma in Situ (DCIS). Can Med Assoc J 2001; 165(7) |
2. Supplement: Clinical practice guidelines for breast ca; The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: The Management of Ductal Carcinoma in Situ (DCIS). Can Med Assoc J 1998; 158 (3 Suppl): S27-34 |
3. Development of clinical practice guidelines; Brouwers MC, Browman GP: Development of Clinical Practice Guidelines: Surgical Perspective. World J Surg. 1999;23:1236-1241 |
4. How to use clinical practice guidelines (a); Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to use Clinical Practice Guidelines. JAMA 1995;274(7): 570-74 |
5. How to use clinical practice guidelines (b); Wilson MC, Hayward RSA, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users' Guide to the Medical Literature. VIII How to Use Clinical Practice Guidelines. JAMA 1995; 274(20):1630-32 |
| | | Reviews |
|
Clinical Review (Can):
|
Hugh Scarth - Dalhousie University
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
December 2002
Topics
|
1. Clinical Topic:
|
U/S in trauma |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being asked?
- Is there an independent, blind comparison with a reference standard?
- Does the study sample include an appropriate spectrum of patients to which the diagnostic test is to be applied?
- Do the results of the test being evaluated influence the decision to perform the reference standard test?
- Are the methods for performing the test described in sufficient detail to permit replication?
- Are likelihood ratios for the test results presented, or is the data necessary for their calculation included?
- Will the reproducibility of the test result and its interpretation be satisfactory in my setting?
- Are the results applicable to my patient?
- Will the results change my management?
- Will patients be better off as a result of the test?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Surgeon performed ultrasound in trauma cases; Rozycki GS, Ballard RB, Feliciano DV, et al: Surgeon-Performed Ultrasound for the Assessment of Truncal Injuries. Annals of Surgery 1998; 228(4): 557-67 |
2. How to use an article about a diagnostic test; Archibald S, Bhandari M, Thoma A, for the Evidence-Based Surgery Working Group. Users' Guides to the Surgical Literature: How to Use an Article About a Diagnostic Test. CJS 2001; 44(1): 17-23 |
| | | Reviews |
|
Clinical Review (Can):
|
Andy Kirkpatrick - University of Calgary
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
November 2002
Topics
|
1. Clinical Topic:
|
ICU |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being asked?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- Is there adequate information to be certain that the investigators had access to raw data, performed the analysis independently and had control over the decision to publish?
- Is the sponsor's role clearly disclosed?
- State the conclusion. Have authors addressed the question posed?
- Does the evidence support the conclusion?
- Is there any concern that the results are possibly invalid due to interference by the sponsor?
|
|
Articles
|
1. Efficacy and safety of recombinant human activated protein C for severe sepsis; Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis. NEJM 2001; 344(10): 699-709/759-62 |
2. Is academic medicine for sale?; Angell M: Is Academic Medicine for Sale? NEJM 2000l; 342(20): 1516-18 |
3. Sponsorship, authorship and accountability; Davidoff F, DeAngelis CD, Drazen JM, et al: Sponsorship, Authorship, and Accountability. NEJM 2001; 345(11): 825-27 |
4. Scietific data from clinical trials; Polk Jr. HC, Bowden Jr. TA Rikkers LF, et al: Scientific Data from Clinical Trials: Investigators' Responsibilities and Rights World J Surg. 2002; 26: 637-38
In addition to these articles, please refer to the Oct. 02 methodological article. |
| | | Reviews |
|
Clinical Review (Can):
|
Nick Christou - McGill University
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
October 2002
Topics
|
1. Clinical Topic:
|
Rectal ca - TME vs. radiation and TME |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Were the study patients similar to my patients?
- Were the measured outcomes clinically relevant?
- Were all clinically important outcomes considered?
- Are my surgical skills similar to those of the study surgeons?
- State the conclusion. Have the authors addressed the question?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Preoperative radiotherapy combined with TME for resectable rectal cancer; Kaiteijn E, Marijnen CAM, Nagtegaal ID, et al: Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer, NEJM 2001; 345(9): 638-46 |
2. How to Use an Article Evaluating Surgical Interventions; Urschel JD, Goldsmith CH, Tandan VR, Miller JD; for the Evidence-Based Surgery Working Group. Users' Guide to Evidence-Based Surgery: How to Use an Article Evaluating Surgical Interventions CJS 2001; 44(2): 95-100 |
| | | Reviews |
|
Clinical Review (Can):
|
Terry Phang - University of British Columbia
|
|
Methodological Review:
|
Carole Richard - University of Montreal
|
May 2002
Topics
|
1. Clinical Topic:
|
Transfusion requirements in critical care |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect? Calculate 95% CI around the difference in 30 day mortality rates between groups.
- State the estimates upon which the sample size was calculated. In retrospect, were they accurate?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Transfusion requirements in critical care; Hébert PC, Wells G, Blajchman MA, et al: A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care NEJM 1999; 340(6): 409-417 |
2. Interpreting study results: confidence intervals; Guyatt G, Jaeschke R, Heddle N, Cook D, Shannon H, Walter S: Basic Statistics for Clinicians: Interpreting Study Results: Confidence Intervals. Can Med Assoc J 1995; 152(2): 169-173 |
| | | Reviews |
|
Clinical Review (Can):
|
John Marshall - University of Toronto
|
|
Methodological Review:
|
Carole Richard - University of Montreal
|
April 2002
Topics
|
1. Clinical Topic:
|
Recurrent Rectal Ca |
|
2. Methodological Topic:
|
Economic Analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the analysis provide a full economic comparison of health care strategies?
- Was a broad enough viewpoint adopted?
- Were all the relevant clinical strategies compared?
- Were the costs and outcomes properly measured and valued?
- Was clinical effectiveness established?
- Were costs measured accurately?
- Were data on costs and outcomes appropriately integrated?
- Was appropriate allowance made for uncertainties in the analysis?
- What were the incremental costs and outcomes of each strategy?
- Do incremental costs and outcomes differ between subgroups?
- Could my patients expect similar health outcomes?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Cost effectiveness analysis of therapy for locally recurrent rectal cancer; Miller AR, Cantor SB, Peoples GE, et al: Quality of Life and Cost Effectiveness Analysis of Therapy for Locally Recurrent Rectal Cancer. Dis Colon Rectum 2000; 43(12): 1695-1703 |
2. How to use an article on economic analsysis (a); Drummond MF, Richardson WS, O'Brien BJ, et al, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. XIII. How to Use an Article on Economic Analysis. JAMA 1997; 277(19): 1552-1557 |
3. How to use an article about economic analysis (b); O'Brein BJ, Heyland D, Richardson WS, et al, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. XIII. How to Use an Article on Economic Analysis. JAMA 1997; 277(22): 1802-1806 |
| | | Reviews |
|
Clinical Review (Can):
|
Geoffrey Porter - Dalhousie University
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
March 2002
Topics
|
1. Clinical Topic:
|
Thyroid Cancer |
|
2. Methodological Topic:
|
Decision Analysis |
| |
|
Questions
|
- What is the clinical question being addressed
- Were all important strategies and outcomes included?
- Were all of the relaistic clinical strategies compared?
- Were all clinically relevant outcomes considered?
- Was an explicit and sensible process used to identify, select and combine the evidence into probabilities?
- Were the utilities obtained in an explicit and sensible way from credible sources?
- Was the potential impact of any uncertainty in the evidence determined?
- Does one strategy result in a clinically important gain for patients?
- How strong is the evidence used in the analysis?
- Could the uncertainty in the evidence change the results>?
- Do the probability estimates fit my patients' clinical features?
- Do the utilities reflect how my patients would value the outcomes of the deicsion?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Total thyroidectomy vs. thyroid lobectomy in patients with low risk differentiated thyroid cancer; Kebebew E, Duh QY, Clark OH; Total Thyroidectomy or Thyroid Lobectomy in Patients with Low-risk Differentiated Thyroid Cancer: Surgical Decision Analysis of a Controversy Using a mathematical Model. World J. Surg. 2000; 24: 1295-1302 |
2. How to use an clinical decision analysis (a);
Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(16): 1292-1295 |
3. How to use a clinical decision analysis (b); Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. VII. How to Use a Clinical Decision Analysis. JAMA 1995; 273(20): 1610-1613 |
| | | Reviews |
|
Clinical Review (Can):
|
Rick Nason - University of Manitoba
|
|
Methodological Review:
|
Carole Richard - University of Montreal
|
February 2002
Topics
|
1. Clinical Topic:
|
AAA |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- What is the study design?
- Did the authors appropriately define the "cases"
- How were cases diagnosed?
- What is the population?
- Are the results generalizable to your own population?
- What are the strengths of the study?
- What are the possible sources of bias?
- Did the authors measure the incidence or prevalence of AAA?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
- How may this information be helpful in clinical practice or future research?
|
|
Articles
|
1. Routine ultrasound screening for abdominal aortic aneurysm among 65 - and 75- year old men; Vasquez C, Sakalihasan N, D'Harcour JB and Limet R: Routine Ultrasound Screening for Abdominal Aortic Aneursym among 65- and 75- Year-Old Men in a City of 200,000 Inhabitants. Annals of Vascular Surgery 1998; 12(6): 544-549 (no link available) |
2. Frequency in clinical epidemiology-the essentials; Frequency in: Clinical Epidemiology-the essentials (Williams & Wilkins, Ed) Waverly Press Inc. 1982: 75-90 (no link available) |
| | | Reviews |
|
Clinical Review (Can):
|
Daryl Kucey - University of Toronto
|
|
Methodological Review:
|
Andrew Hill - University of Ottawa
|
January 2002
Topics
|
1. Clinical Topic:
|
Pulmonary Embolus |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being asked?
- Is this a question of diagnosis or screening?
- Was there an independent, blind comparison to a gold standard test?
- Did the patient sample include an appropriate spectrum of patients?
- Did the results of the test being evaluated influence the decision to perform the reference standard?
- Were the methods for performing the test adequately described?
- Were likelihood ratios for the test results presented or data necessary for their calculation included?
- Will the reproducibility of the test results and its interpretation be satisfactory in my setting?
- Are the results applicable to my patients?
- Will the results change my management?
- Will patients be better off as a result of the test?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Prospective evaluation of dual section helical CT vs. selective angiography in pulomonary embolism detection; Qanadli S, Hajjam ME, Barré O, et al. Pulmonary Embolism Detection: Prospective Evaluation of Dual-Section Helical CT versus Selective Pulmonary Arteriography in 157 Patients. Radiology 2000; 217(2): 447-455 (no link avialable) |
2. How to use an article about a diagnostic test (a); Jaeschke R, Guyatt G, Sackett DL, for the Evidence-Based Medicine Working Group. User's Guides to the Medical Literature. III How to Use an Article About a Diagnostic Test. JAMA 1994; 271(5): 389-391 |
3. How to use an article about a diagnostic test (b); Jaeschke R, Guyatt G, Sackett DL, for the Evidence-Based Medicine Working Group. User's Guides to the Medical Literature. III How to Use an Article About a Diagnostic Test. JAMA 1994; 271(9): 703-707 |
| | | Reviews |
|
Clinical Review (Can):
|
John Drover - Queen's Unviersity
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
December 2001
Topics
|
1. Clinical Topic:
|
Prophylactic Mastectomy |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
|
In this session, we will focus on the issue of how to measure treatment. In addition please consider the following issues:
- What is the clinical question being addressed?
- What is the design of the study?
- What are the potential biases in this study?
- Would it be possible to perform a randomized controlled trial to address this question? What would be some of the issues that might make it difficult to perform a randomized controlled trial?
- Using the unadjusted data in Tables 5 and 6 calculate the following:
- Relative risk reduction
- Odds ratio
- Absolute risk reduction
- Number needed to treat
For all of the above calculate both the number of breast cancers and the number of deaths.
In doing so, assume that the expected number of deaths were actually observed in a second cohort of woman. Secondly, that n in both groups = 214.
|
|
Articles
|
1. Efficacy of bilateral prohylactic mastecteomy in women with a family history of breast cancer; Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of Bilateral Prophylactic Mastectomy in women with a Family History of Breast Cancer. NEJM 1999; 340(2): 77-84 |
2. Assessing the effects of treatment; Jaeschke R, Guyatt G, Shannon H, et al: Assessing the Effects of Treatment: Measures of Association. CMAJ 1995; 152: 351-357 |
| | | Reviews |
|
Clinical Review (Can):
|
Rona Chiefetz - Univesity of British Columbia
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
November 2001
Topics
|
1. Clinical Topic:
|
Incisional Hernia |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Was there adequate blinding of patients, their clinicians and study personnel?
- Were the groups similar at the start of the trial?
- Was there adequate standardization of the surgical procedure?
- How large and precise was the treatment effect?
- Are the procedures adequately described so that they can be used in your own patient care?
- Are the surgical techniques that were compared still relevant or have they been supplanted by newer procedures?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Suture vs. mesh repair for incisional hernia; Luijendijk RW, Hop WCJ, Van Den Tol P, et al: A Comparison of Suture Repair with Mesh Repair for Incisional Hernia Repair. NEJM 2000; 343 (6): 392-398 |
2. Issues in surgical randomized controlled trials; McLeod, RS: Issues in Surgical Randomized Controlled Trials. World J. Surg 1999; 23: 1210-1214 |
| | | Reviews |
|
Clinical Review (Can):
|
John Bohnen - University of Toronto
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
October 2001
Topics
|
1. Clinical Topic:
|
Duodenal Ulcers |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Endoscopic retreatment vs. surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers; Lau JYW, Sung JJY, Lam YH, et al: Endoscopic Retreatment Compared With Surgery In Patients with Recurrent Bleeding After Initial Endoscopic Control of Bleeding Ulcers. NEJM 1999; 340 (10): 751-756 |
2. How to use an article about therapy or prevention (a); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1993 Dec 1; 270(21): 2598-2601 |
3. How to use an article about therapy or prevention (b); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1994 Jan 5; 271(1): 59-63 |
| | | Reviews |
|
Clinical Review (Can):
|
Stewart Hamilton - University of Alberta
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
May 2001
Topics
|
1. Clinical Topic:
|
Vascular surgery |
|
2. Methodological Topic:
|
Health Services Research |
| |
|
Questions
|
- What is the clinical question being addressed?
- Are the outcome measures accurate and comprehensive?
- Were the comparison groups similar with respect to important determinants of outcome, other than the one of interest?
- Were there clearly identified, sensible comparison groups?
- Were residual differences adjusted for in the analysis?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Relation of surgical volume to outcome; Khuri SF, Daley J, Henderson W, Hur K, Hossain M, et al: Relation of Surgical Volume to Outcome in Eight Common Operations. Annals of Surgery 1999; 230 (3): 414-432 |
2. How to use an article reporting variations in the ourcomes of health services; Naylor CD, Guyatt GH, for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. X. How to Use an Article Reporting Variations in the Outcomes of Health Services. JAMA 1996; 275 (7): 554-558 |
| | | Reviews |
|
Clinical Review (Can):
|
Marko Simunovic - McMaster University
|
|
Methodological Review:
|
Andrew Hill - University of Ottawa
|
April 2001
Topics
|
1. Clinical Topic:
|
Pnuemonia in ICU |
|
2. Methodological Topic:
|
Causation/Risk Factors |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were there clearly identified comparison groups that were similar with respect to important determinants of outcome other than the one of interest?
- Were the exposures and outcomes measured in the same way in the groups being compared?
- Was follow-up sufficiently long and complete?
- Is the temporal relationship correct?
- Is there a dose-response gradient?
- How strong is the association between exposure and outcome?
- How precise is the estimate of the risk?
- Are the results applicable to my practice?
- What is the magnitude of the risk?
- Should I attempt to stop the exposure?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Risk factors for ventilator associated pnuemonia in critically ill patietns; Cook DJ, Walker SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeshke RZ, Brun-Buisson C, for the Canadian Critical Care Trials Group. Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients. Annals of Medicine 1998; 129(6): 433-440 (no link available) |
2. How to use an article about harm; Mitchell L, Walter S, Lee H, Haines T, Holbrook A, Moyer V, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature. IV. How to Use an Article about Harm. JAMA 1994; 271(20): 1615-1619 |
| | | Reviews |
|
Clinical Review (Can):
|
John Marshall - University of Toronto
|
|
Methodological Review:
|
Harry Heteleff - Dalhousie University
|
March 2001
Topics
|
1. Clinical Topic:
|
Surgical options for early stage breast cancer |
|
2. Methodological Topic:
|
Quality of Life |
| |
|
Questions
|
- What is the clinical question being addressed?
- Did the HRQL Instruments work in the way they are supposed to?
- Are there important aspects of HRQL that they have been omitted?
- If there were trade-offs between quality and quantity of life, or an economic evaluation, have the investigators used the right measures?
- What was the magnitude of effect on HRQL?
- Will the results help me in caring for my patients?
- Did the study design simulate clinical practice?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Surgical Options for early stage breast cancer; Pusic A, Thompson TA, Kerrigan CL, Sargeant R, Slezak S, Chang BW, Helzlsouer KJ: Surgical Options for Early-Stage Breast Cancer: Factors Associated with Patient Choice and Postoperative Quality of Life. Plastic and Reconstructive Surgery 1999; 104 (5): 1325-1333 (no link available) |
2. How to use an article about health related quality of life; Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ, for the Evidence-Based Medicine Working Group: User's Guide to the Medical Literature. XII. How to Use Articles About Health-Related Quality of Life. JAMA 1997; 277 (15): 1232-1237 |
| | | Reviews |
|
Clinical Review (Can):
|
Steven Latosinsky - University of Manitoba
|
|
Methodological Review:
|
Carole Richard - University of Montreal
|
February 2001
Topics
|
1. Clinical Topic:
|
Hyperparathyroidism |
|
2. Methodological Topic:
|
Prognosis/Natural History |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was there a representative and well-defined sample of patients at a similar point in the course of the disease?
- Was follow-up sufficiently long and complete?
- Were objective and unbiased outcome criteria used?
- Was there adjustment for important prognostic factors?
- How large is the likelihood of the outcome event(s) in a specified period of time?
- How precise are the estimates of likelihood?
- Will the results help me in caring for my patients?
- Will the results lead directly to selecting or avoiding therapy?
- Are the results useful for reassuring or counseling patients?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
|
|
Articles
|
1. Prospective study of primary hyperparathyroidism; Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP: A 10 - Year Prospective Study of Primary Hyperparathyroidism With or Without Parathyroid Surgery. NEJM 1999; 341: 1249-1255 |
2. Treatment of hyperparathryoidism; Utiger RD. Editorials: Treatment of Primary Hyperparathyroidism. NEJM 1999; 341: 1301-1302 |
3. How to use an article about prognosis; Laupacis A, Wells G, Richardson WS, Tugwell P, for The Evidence-Based Working Group: Users' Guides to the Medical Literature. V. How to Use an Article About Prognosis. JAMA 1994; 272: 234-237 |
| | | Reviews |
|
Clinical Review (Can):
|
Noelle Davis - University of British Columbia
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
January 2001
Topics
|
1. Clinical Topic:
|
Virtual colonoscopy |
|
2. Methodological Topic:
|
Diagnostic Tests |
| |
|
Questions
|
- What is the clinical question being asked?
- Is this a question of diagnosis or screening?
- Was there an independent, blind comparison to a gold standard test?
- Did the patient sample include an appropriate spectrum of patients?
- Did the results of the test being evaluated influence the decision to perform the gold standard test?
- Were the methods for performing the test adequately described?
- Were likelihood ratios for the test results presented or data necessary for their calculation provided?
- Will the reproducibility of the test results be satisfactory in my setting?
- Are the results applicable to my patients?
- Will the results change my management?
- Will patients be better off as a result of the test?
|
|
Articles
|
1. Virtual colonoscopy; Fenlon HM, Nunes DP, Schroy III PC et al: A comparison of Virtual and Conventional Colonoscopy for the Detection of Colorectal Polyps. NEJM 1999; 341: 1496-1503 |
2. How to use an article about a diagnostic test (a); Jaeschke R, Guyatt GH, Sackett DL: for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. III. How to Use an Article about a Diagnostic Test. A. JAMA 1994 Feb 2; 271(5): 389-391 |
3. How to use an article about a diagnostic test (b); Jaeschke R, Guyatt GH, Sackett DL: for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. III. How to Use an Article about a Diagnostic Test. B. JAMA 1994 Mar 2; 271(9): 703-707 |
| | | Reviews |
|
Clinical Review (Can):
|
Zane Cohen - University of Toronto
|
|
Methodological Review:
|
Mark Taylor - University of Manitoba
|
December 2000
Topics
|
1. Clinical Topic:
|
ERCP vs. Lap cholecystectomy |
|
2. Methodological Topic:
|
Number Needed to Treat/Confidence Intervals/Equivalence |
| |
|
Questions
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed?
- Does the evidence support the conclusion?
You may refer to the methodology article distributed Oct. 2000 on "How to assess an article detrmining treatment effectiveness"
|
|
Articles
|
1. ERCP vs. Lap cholecystectomy; Cushieri A, Lezoche E, Morino, M et al: E.A.E.S. Multicentre prospective randomized trial comparing two-stage vs single stage management of patients with gallstone disease and ductal calculi. Surg Endosc (1999) 13: 952-957 (no link available) |
2. Interpreting study results: confidence intervals; Guyatt G, Jaeschke R, Heddle N, Cook D, Shannon H, Walter S: Basic Statistics for Clinicians: Interpreting Study Results: Confidence Intervals. Can Med Assoc J (1995) Jan 15; 152 (2): 169-173 |
| | | Reviews |
|
Clinical Review (Can):
|
Roger Keith - University of Sasketchewan
|
|
Methodological Review:
|
Jeffrey Barkun - McGill Unviersity
|
November 2000
Topics
|
1. Clinical Topic:
|
Lap. vs. conventional hernia repair |
|
2. Methodological Topic:
|
Meta-analysis |
| |
|
Questions
|
- What is the clinical question being addressed?
- Were the criteria used to select articles for inclusion
- Is it unlikely that important relevant studies were missed?
- Was the validity of the included studies appraised?
- Were assessments of the studies reproducible?
- Were the results similar from study to study?
- What are the overall results of the overview? How precise were the results?
- Were all clinically important outcomes considered?
- Are the benefits worth the harms and costs?
- State the conclusion. Have the authors’ addressed the question posed? Does the evidence support the conclusion?
|
|
Articles
|
1. Laparosocopic vs. conventional inguinal hernia repairs; Chung RS, Rowland DY: Meta-analyses of randomized controlled trials of laparoscopic vs conventional inguinal hernia repairs. Surg Endosc 1999; 13: 689-694 (no link available) |
2. How to use an overview; Oxman AD, Cook DJ, Guyatt GH, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. VI. How to Use an Overview. JAMA 1994; 272: 1367-1371 |
| | | Reviews |
|
Clinical Review (Can):
|
Lloyd Smith - University of Toronto
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
October 2000
Topics
|
1. Clinical Topic:
|
Open vs. Lap Nissen |
|
2. Methodological Topic:
|
Treatment Effectiveness |
| |
|
Questions
|
|
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized?
- Were all patients who entered the trial properly accounted for and attributed at its conclusions?
- Were patients, their clinicians and study personnel "blind" to treatment?
- Were the groups similar at the start of the trial?
- Aside from the experimental intervention, were the groups treated equally?
- How large and precise was the treatment effect?
- Can the results be applied to my patient care?
- Were all clinically important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the question posed? Does the evidence support the conclusion
|
|
Articles
|
1. Open vs. Lap Nissen; Bais JE, Bartelsman JFWM, et al: Laproscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. Lancet 2000; 355: 170-174 |
2. How to use an article about therapy or prevention (a); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1994 Jan 5; 271(1): 59-63 |
3. How to use an article about therapy or prevention (b); Guyatt GH, Sackett DL, Cook DJ, for the Evidence Based Medicine Working Group. Users’ Guides to the Medical Literature. II. How to Use an Article about Therapy or Prevention. JAMA 1993 Dec 1; 270(21): 2598-2601 |
| | | Reviews |
|
Clinical Review (Can):
|
Richard Finley - University of British Columbia
|
|
Methodological Review:
|
Robin McLeod - University of Toronto
|
|
| |
|
| |
|
| |
|
|